Page last updated: 2024-10-20

phosphorylethanolamine and Canine Diseases

phosphorylethanolamine has been researched along with Canine Diseases in 2 studies

phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Alisauskaite, N1
Beckmann, K1
Dennler, M1
Zölch, N1
Kyöstilä, K1
Syrjä, P1
Lappalainen, AK1
Arumilli, M1
Hundi, S1
Karkamo, V1
Viitmaa, R1
Hytönen, MK1
Lohi, H1

Other Studies

2 other studies available for phosphorylethanolamine and Canine Diseases

ArticleYear
Brain proton magnetic resonance spectroscopy findings in a Beagle dog with genetically confirmed Lafora disease.
    Journal of veterinary internal medicine, 2020, Volume: 34, Issue:4

    Topics: Animals; Aspartic Acid; Brain; Choline; Dog Diseases; Dogs; Ethanolamines; Female; Glutamic Acid; Gl

2020
A homozygous missense variant in the alkaline phosphatase gene ALPL is associated with a severe form of canine hypophosphatasia.
    Scientific reports, 2019, 01-30, Volume: 9, Issue:1

    Topics: Alkaline Phosphatase; Amino Acid Sequence; Animals; Breeding; Calcification, Physiologic; Conserved

2019